AU2008225828A1 - Markers, antibodies and recombinant scFvs for mesenchymal stem cell-sub-populations and osteoclasts - Google Patents

Markers, antibodies and recombinant scFvs for mesenchymal stem cell-sub-populations and osteoclasts Download PDF

Info

Publication number
AU2008225828A1
AU2008225828A1 AU2008225828A AU2008225828A AU2008225828A1 AU 2008225828 A1 AU2008225828 A1 AU 2008225828A1 AU 2008225828 A AU2008225828 A AU 2008225828A AU 2008225828 A AU2008225828 A AU 2008225828A AU 2008225828 A1 AU2008225828 A1 AU 2008225828A1
Authority
AU
Australia
Prior art keywords
seq
cells
antibody
polypeptide
mscs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2008225828A
Other languages
English (en)
Inventor
Frank Barry
Tyrone Villalard Bowes
William James Johnathan Finlay
Udo Greiser
Timothy O'brien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Galway
Original Assignee
University of Galway
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Galway filed Critical University of Galway
Publication of AU2008225828A1 publication Critical patent/AU2008225828A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AU2008225828A 2007-03-12 2008-03-12 Markers, antibodies and recombinant scFvs for mesenchymal stem cell-sub-populations and osteoclasts Abandoned AU2008225828A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IE20070170 2007-03-12
IE2007/0170 2007-03-12
IE2008/0015 2008-01-11
IE20080015 2008-01-11
PCT/EP2008/052959 WO2008110578A2 (en) 2007-03-12 2008-03-12 Markers, antibodies and recombinant scfvs for mesenchymal stem cell-sub-populations and osteoclasts

Publications (1)

Publication Number Publication Date
AU2008225828A1 true AU2008225828A1 (en) 2008-09-18

Family

ID=39540751

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008225828A Abandoned AU2008225828A1 (en) 2007-03-12 2008-03-12 Markers, antibodies and recombinant scFvs for mesenchymal stem cell-sub-populations and osteoclasts

Country Status (6)

Country Link
US (1) US20100062038A1 (enExample)
EP (1) EP2118272A2 (enExample)
JP (1) JP2010520761A (enExample)
AU (1) AU2008225828A1 (enExample)
CA (1) CA2688121A1 (enExample)
WO (1) WO2008110578A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655041B2 (en) 2007-05-01 2010-02-02 Moximed, Inc. Extra-articular implantable mechanical energy absorbing systems and implantation method
FR2953023B1 (fr) * 2009-11-23 2011-12-09 Commissariat Energie Atomique Utilisation d'une isoforme d'hla-g comme marqueur de l'osteogenese

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001239729A1 (en) * 2000-09-12 2002-03-26 Human Genome Sciences, Inc. 22 human secreted proteins

Also Published As

Publication number Publication date
WO2008110578A3 (en) 2009-01-15
JP2010520761A (ja) 2010-06-17
WO2008110578A2 (en) 2008-09-18
US20100062038A1 (en) 2010-03-11
CA2688121A1 (en) 2008-09-18
EP2118272A2 (en) 2009-11-18

Similar Documents

Publication Publication Date Title
CA2734210C (en) Monoclonal antibody stro-4
US9052316B2 (en) Isolation and/or identification of stem cells having adipocytic, chondrocytic and pancreatic differentiation potential
CA2581237C (en) Method of enhancing proliferation and/or survival of mesenchymal precursor cells (mpc)
EP0719330B1 (en) Protocadherin proteins and their uses
JP4922548B2 (ja) 体性幹細胞の同定および単離ならびにその使用
KR100241863B1 (ko) 아포토시스를 야기시키는 모노클론성항체
JPH05509312A (ja) 組織由来の腫瘍増殖インヒビター，その調製方法及び使用
WO2007019107A2 (en) Adipose tissue stem cells, perivascular cells and pericytes
JP2003523735A (ja) ヒトナチュラルキラー細胞によって媒介される天然細胞毒性に関連した新規トリガリングレセプターおよび同一の性質を有する抗体
US20100062038A1 (en) Markers, Antibodies and Recombinant scFvs for Mesenchymal Stem Cell Sub-populations and Osteoclasts
WO2014018230A2 (en) Methods to isolate human mesenchymal stem cells
JP2019502674A (ja) 組織形成誘導用化合物及びその使用
CN112126620A (zh) 基因编辑提高脂肪干细胞分化效率的方法
EA023016B1 (ru) Составной белок
JP2001508651A (ja) Ｋａｌタンパク質を含んでなる治療組成物および網膜、腎臓、ニューロンおよび神経の損傷を治療するためのｋａｌタンパク質の使用
JP2017063669A (ja) 合成ペプチドを用いた神経幹細胞の生産方法
CN112430269B (zh) 一种促进脐带血干细胞成骨分化的组合物及其应用
EP2843048B1 (en) NOVEL INTEGRIN alpha9beta1 LIGAND AND USES THEREOF
KR100274791B1 (ko) 간질세포표면항원을 인식하는 모노클론성항체
WO2011156639A1 (en) Eiiia and eiiib segments of fibronectin regulate stem cell fate
US20110159012A1 (en) Method for isolating neural cells using tenascin-r compounds
US20130156819A1 (en) Isolation of mesenchymal stem cells
JP2007534946A (ja) 幹細胞に特異的に結合するモノクローナル抗体の使用
Class et al. Patent application title: MONOCLONAL ANTIBODY STRO-4 Inventors: Stan Gronthos (Adelaide, AU) Andrew Christopher William Zannettino (Highbury, AU) Assignees: MESOBLAST, INC.
KR20090055964A (ko) 골수유래 중간엽 줄기세포의 분리방법

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application